Retractable Technologies (RVP) Competitors $0.69 -0.01 (-2.06%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock RVP vs. FONR, NSPR, SRTS, MLSS, ZYXI, CTSO, ICCM, VANI, INO, and NTRBShould you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include FONAR (FONR), InspireMD (NSPR), Sensus Healthcare (SRTS), Milestone Scientific (MLSS), Zynex (ZYXI), Cytosorbents (CTSO), IceCure Medical (ICCM), Vivani Medical (VANI), Inovio Pharmaceuticals (INO), and Nutriband (NTRB). These companies are all part of the "medical equipment" industry. Retractable Technologies vs. FONAR InspireMD Sensus Healthcare Milestone Scientific Zynex Cytosorbents IceCure Medical Vivani Medical Inovio Pharmaceuticals Nutriband FONAR (NASDAQ:FONR) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk. Does the MarketBeat Community favor FONR or RVP? FONAR received 180 more outperform votes than Retractable Technologies when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 0.00% of users gave Retractable Technologies an outperform vote. CompanyUnderperformOutperformFONAROutperform Votes18074.69% Underperform Votes6125.31% Retractable TechnologiesOutperform VotesNo VotesUnderperform Votes91100.00% Which has more volatility & risk, FONR or RVP? FONAR has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 2.28, indicating that its share price is 128% more volatile than the S&P 500. Is FONR or RVP more profitable? FONAR has a net margin of 7.68% compared to Retractable Technologies' net margin of -41.11%. FONAR's return on equity of 4.94% beat Retractable Technologies' return on equity.Company Net Margins Return on Equity Return on Assets FONAR7.68% 4.94% 3.70% Retractable Technologies -41.11%-17.15%-9.33% Which has preferable earnings and valuation, FONR or RVP? FONAR has higher revenue and earnings than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFONAR$101.57M0.74$10.57M$1.1510.49Retractable Technologies$33.05M0.63-$7.01M-$0.41-1.69 Do insiders & institutionals hold more shares of FONR or RVP? 50.6% of FONAR shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 2.2% of FONAR shares are held by insiders. Comparatively, 55.0% of Retractable Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to FONR or RVP? In the previous week, Retractable Technologies had 4 more articles in the media than FONAR. MarketBeat recorded 6 mentions for Retractable Technologies and 2 mentions for FONAR. FONAR's average media sentiment score of 0.44 beat Retractable Technologies' score of 0.42 indicating that FONAR is being referred to more favorably in the media. Company Overall Sentiment FONAR Neutral Retractable Technologies Neutral SummaryFONAR beats Retractable Technologies on 12 of the 15 factors compared between the two stocks. Remove Ads Get Retractable Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVP vs. The Competition Export to ExcelMetricRetractable TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$20.75M$4.07B$5.29B$18.33BDividend YieldN/A39.51%5.11%4.23%P/E Ratio-1.2827.7621.6930.99Price / Sales0.6350.01371.6225.38Price / Cash48.2551.0838.1517.53Price / Book0.215.836.374.26Net Income-$7.01M$67.64M$3.20B$1.02B7 Day Performance-1.00%-0.79%1.67%-1.29%1 Month Performance-5.20%-3.80%-9.49%-7.34%1 Year Performance-35.22%14.21%9.59%1.23% Retractable Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVPRetractable TechnologiesN/A$0.69-2.1%N/A-33.9%$20.75M$33.05M-1.28240Gap DownFONRFONAR1.31 of 5 stars$13.00-2.8%N/A-27.9%$80.64M$101.57M11.30480Short Interest ↑NSPRInspireMD2.0187 of 5 stars$2.59-1.9%$4.75+83.4%+8.4%$76.90M$7.01M-3.4550Gap UpSRTSSensus Healthcare2.4797 of 5 stars$4.48+0.4%$13.00+190.2%+45.3%$73.90M$41.81M11.2040Gap DownMLSSMilestone Scientific1.6163 of 5 stars$0.89+2.3%$1.25+40.4%+65.5%$69.32M$8.88M-12.7130Analyst ForecastNews CoverageGap DownZYXIZynex2.9939 of 5 stars$2.16flat$10.25+374.5%-81.6%$65.29M$192.35M14.40770Analyst ForecastHigh Trading VolumeCTSOCytosorbents2.1203 of 5 stars$0.99+2.1%$4.67+371.1%+16.5%$61.91M$35.59M-2.75220ICCMIceCure Medical2.4273 of 5 stars$1.11-2.6%$2.50+125.2%-17.0%$61.61M$3.29M-3.8360Gap DownVANIVivani Medical2.8296 of 5 stars$1.02+6.3%$4.00+292.2%-49.0%$60.42MN/A-2.2720Analyst ForecastShort Interest ↑News CoverageINOInovio Pharmaceuticals3.4267 of 5 stars$1.58+1.3%$12.20+672.2%-84.0%$57.93M$217,756.00-0.40320Short Interest ↑High Trading VolumeNTRBNutriband2.9058 of 5 stars$5.09-5.7%$13.00+155.4%+25.6%$56.53M$2.02M-7.1710Gap Down Remove Ads Related Companies and Tools Related Companies FONR Competitors NSPR Competitors SRTS Competitors MLSS Competitors ZYXI Competitors CTSO Competitors ICCM Competitors VANI Competitors INO Competitors NTRB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RVP) was last updated on 4/16/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Retractable Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Retractable Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.